Dr. Lal Pathlabs Q2 FY27: revenue up 19.6% to ₹874 Cr, net profit up 27.4% to ₹194 Cr
Results · Finvezto · 4 Nov 2026 · Dr. Lal Pathlabs (LALPATHLAB)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 874 | +9.6% | +19.6% |
| Operating profit | 280 | +13.2% | +25.0% |
| Net profit | 194 | +13.7% | +27.4% |
| Operating margin | 32.1% | +1.0 pp | +1.4 pp |
| Net margin | 22.2% | +0.8 pp | +1.4 pp |
Key points
- Dr Lal PathLabs Limited reported consolidated revenue of Rs 874 crore for Q2 FY27, up 19.6% from Rs 731 crore in Q2 FY26, with EBITDA rising 25.1% to Rs 280 crore from Rs 224 crore and profit after tax increasing 27.5% to Rs 194 crore from Rs 152 crore. NSE filing
- The board declared an interim dividend of Rs 5 per share, while cash and cash equivalents stood at Rs 1,746 crore as of September 30, 2026. NSE filing
- Revenue was ₹874 Cr, up 19.6% on a year earlier and up 9.6% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 27.2%, 26.6%, 31.0%, 32.1%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 91, 132, 171, 194.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.